Search

for
Search:

GlossaryErlotinib

medication that inhibits cancer cell growth by targeting EGFR

Erlotinib is a medication used to treat certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By blocking this receptor, erlotinib can help slow down or stop the progression of the disease.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 199 results

research Folliculitis Decalvans Associated with Erlotinib

25 citations , April 2010 in “Clinical and Experimental Dermatology”

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

research Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture

15 citations , October 2014 in “The journal of investigative dermatology/Journal of investigative dermatology”

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

research Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-Small Cell Lung Cancer

12 citations , November 2006 in “Journal of thoracic oncology”

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

research Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review

1 citations , April 2025 in “Clinical Cosmetic and Investigational Dermatology”

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

research Topical Application of Aprepitant Inhibits Erlotinib-Induced Facial Dermatitis and Hair Loss

January 2024 in “Journal of dermatology and skin science”

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

View more "erlotinib" in research →

Community Join

0 / 0 results

— no results